RNF2 promotes chondrosarcoma progression by regulating ubiquitination and degradation of CBX7
Abstract Objective Chondrosarcoma (CHS) is resistant to conventional chemotherapy and radiotherapy and currently lacks effective treatment options when in advanced stages. Accordingly, this research investigated the mechanism of RNF2/CBX7 in CHS to drive the development of molecularly targeted drugs...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-10-01
|
| Col·lecció: | Cancer & Metabolism |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s40170-024-00359-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|